209 related articles for article (PubMed ID: 28743496)
1. WNK4 is indispensable for the pathogenesis of pseudohypoaldosteronism type II caused by mutant KLHL3.
Susa K; Sohara E; Takahashi D; Okado T; Rai T; Uchida S
Biochem Biophys Res Commun; 2017 Sep; 491(3):727-732. PubMed ID: 28743496
[TBL] [Abstract][Full Text] [Related]
2. Phenotypes of pseudohypoaldosteronism type II caused by the WNK4 D561A missense mutation are dependent on the WNK-OSR1/SPAK kinase cascade.
Chiga M; Rafiqi FH; Alessi DR; Sohara E; Ohta A; Rai T; Sasaki S; Uchida S
J Cell Sci; 2011 May; 124(Pt 9):1391-5. PubMed ID: 21486947
[TBL] [Abstract][Full Text] [Related]
3.
Sasaki E; Susa K; Mori T; Isobe K; Araki Y; Inoue Y; Yoshizaki Y; Ando F; Mori Y; Mandai S; Zeniya M; Takahashi D; Nomura N; Rai T; Uchida S; Sohara E
Mol Cell Biol; 2017 Apr; 37(7):. PubMed ID: 28052936
[TBL] [Abstract][Full Text] [Related]
4. Activation of the thiazide-sensitive Na+-Cl- cotransporter by the WNK-regulated kinases SPAK and OSR1.
Richardson C; Rafiqi FH; Karlsson HK; Moleleki N; Vandewalle A; Campbell DG; Morrice NA; Alessi DR
J Cell Sci; 2008 Mar; 121(Pt 5):675-84. PubMed ID: 18270262
[TBL] [Abstract][Full Text] [Related]
5. The WNK1 and WNK4 protein kinases that are mutated in Gordon's hypertension syndrome phosphorylate and activate SPAK and OSR1 protein kinases.
Vitari AC; Deak M; Morrice NA; Alessi DR
Biochem J; 2005 Oct; 391(Pt 1):17-24. PubMed ID: 16083423
[TBL] [Abstract][Full Text] [Related]
6. WNK1 regulates phosphorylation of cation-chloride-coupled cotransporters via the STE20-related kinases, SPAK and OSR1.
Moriguchi T; Urushiyama S; Hisamoto N; Iemura S; Uchida S; Natsume T; Matsumoto K; Shibuya H
J Biol Chem; 2005 Dec; 280(52):42685-93. PubMed ID: 16263722
[TBL] [Abstract][Full Text] [Related]
7. Targeted disruption of the Wnk4 gene decreases phosphorylation of Na-Cl cotransporter, increases Na excretion and lowers blood pressure.
Ohta A; Rai T; Yui N; Chiga M; Yang SS; Lin SH; Sohara E; Sasaki S; Uchida S
Hum Mol Genet; 2009 Oct; 18(20):3978-86. PubMed ID: 19633012
[TBL] [Abstract][Full Text] [Related]
8. WNK kinases regulate thiazide-sensitive Na-Cl cotransport.
Yang CL; Angell J; Mitchell R; Ellison DH
J Clin Invest; 2003 Apr; 111(7):1039-45. PubMed ID: 12671053
[TBL] [Abstract][Full Text] [Related]
9. Dietary salt regulates the phosphorylation of OSR1/SPAK kinases and the sodium chloride cotransporter through aldosterone.
Chiga M; Rai T; Yang SS; Ohta A; Takizawa T; Sasaki S; Uchida S
Kidney Int; 2008 Dec; 74(11):1403-9. PubMed ID: 18800028
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of type I and type II pseudohypoaldosteronism.
Furgeson SB; Linas S
J Am Soc Nephrol; 2010 Nov; 21(11):1842-5. PubMed ID: 20829405
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of NCC and NKCC2 cotransporters by kidney-specific WNK1 revealed by gene disruption and transgenic mouse models.
Liu Z; Xie J; Wu T; Truong T; Auchus RJ; Huang CL
Hum Mol Genet; 2011 Mar; 20(5):855-66. PubMed ID: 21131289
[TBL] [Abstract][Full Text] [Related]
12. SPAK/OSR1 regulate NKCC1 and WNK activity: analysis of WNK isoform interactions and activation by T-loop trans-autophosphorylation.
Thastrup JO; Rafiqi FH; Vitari AC; Pozo-Guisado E; Deak M; Mehellou Y; Alessi DR
Biochem J; 2012 Jan; 441(1):325-37. PubMed ID: 22032326
[TBL] [Abstract][Full Text] [Related]
13. Functional interactions of the SPAK/OSR1 kinases with their upstream activator WNK1 and downstream substrate NKCC1.
Vitari AC; Thastrup J; Rafiqi FH; Deak M; Morrice NA; Karlsson HK; Alessi DR
Biochem J; 2006 Jul; 397(1):223-31. PubMed ID: 16669787
[TBL] [Abstract][Full Text] [Related]
14. Molecular pathogenesis of pseudohypoaldosteronism type II: generation and analysis of a Wnk4(D561A/+) knockin mouse model.
Yang SS; Morimoto T; Rai T; Chiga M; Sohara E; Ohno M; Uchida K; Lin SH; Moriguchi T; Shibuya H; Kondo Y; Sasaki S; Uchida S
Cell Metab; 2007 May; 5(5):331-44. PubMed ID: 17488636
[TBL] [Abstract][Full Text] [Related]
15. WNK4 inhibits NCC protein expression through MAPK ERK1/2 signaling pathway.
Zhou B; Wang D; Feng X; Zhang Y; Wang Y; Zhuang J; Zhang X; Chen G; Delpire E; Gu D; Cai H
Am J Physiol Renal Physiol; 2012 Mar; 302(5):F533-9. PubMed ID: 22114204
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of regulation of renal ion transport by WNK kinases.
Huang CL; Yang SS; Lin SH
Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):519-25. PubMed ID: 18695394
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II signaling increases activity of the renal Na-Cl cotransporter through a WNK4-SPAK-dependent pathway.
San-Cristobal P; Pacheco-Alvarez D; Richardson C; Ring AM; Vazquez N; Rafiqi FH; Chari D; Kahle KT; Leng Q; Bobadilla NA; Hebert SC; Alessi DR; Lifton RP; Gamba G
Proc Natl Acad Sci U S A; 2009 Mar; 106(11):4384-9. PubMed ID: 19240212
[TBL] [Abstract][Full Text] [Related]
18. Effect of angiotensin II on the WNK-OSR1/SPAK-NCC phosphorylation cascade in cultured mpkDCT cells and in vivo mouse kidney.
Talati G; Ohta A; Rai T; Sohara E; Naito S; Vandewalle A; Sasaki S; Uchida S
Biochem Biophys Res Commun; 2010 Mar; 393(4):844-8. PubMed ID: 20175999
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiological roles of WNK kinases in the kidney.
Uchida S
Pflugers Arch; 2010 Sep; 460(4):695-702. PubMed ID: 20490538
[TBL] [Abstract][Full Text] [Related]
20. The regulation of salt transport and blood pressure by the WNK-SPAK/OSR1 signalling pathway.
Richardson C; Alessi DR
J Cell Sci; 2008 Oct; 121(Pt 20):3293-304. PubMed ID: 18843116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
